The risk factors for the development of BCBM are patient characteristics of younger age and ethnicity, tumor features of poorly differentiated, hormone receptor (HR)‐negative and human epidermal growth factor receptor 2 (HER2)‐positive, more than four metastatic lymph nodes and some genetic variations.3, 4. Here, ERBB2 is linked to neoplasm.